Raymond James Financial Portfolio holdings
Raymond James Financial, founded in 1962 by Robert James and headquartered in St. Petersburg, Florida, is a diversified financial services firm managing over $1.5 trillion in client assets as of late 2024, primarily focused on wealth management, investment banking, and brokerage services. Known for its advisor-centric model, the firm supports over 8,900 financial advisors across the U.S., Canada, and the UK, offering personalized financial planning, retirement solutions, and investment products to individuals, small businesses, and institutions. Its investment banking arm specializes in middle-market mergers, acquisitions, and equity offerings, while its Raymond James Bank provides lending and deposit services. With a reputation for a conservative, client-first culture and steady growth—including a notable acquisition of TriState Capital in 2022—Raymond James stands out as a resilient, relationship-driven player in the financial industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$962M |
| 2 |
AbbVie
ABBV
|
+$512M |
| 3 |
Bank of America
BAC
|
+$172M |
| 4 |
TJX Companies
TJX
|
+$157M |
| 5 |
GE Vernova
GEV
|
+$156M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$636M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$388M |
| 3 |
Palantir
PLTR
|
+$253M |
| 4 |
Applovin
APP
|
+$236M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$212M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 39.84% |
| 2 | Technology | 16.54% |
| 3 | Financials | 9.27% |
| 4 | Industrials | 6.9% |
| 5 | Healthcare | 6.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3976
First Trust Nasdaq Transportation ETF
FTXR
$961M
| $527K | ﹤0.01% |
+16,675
| New | +$500K |
2025 Q2
0 quarters
|
|
3977
Xtrackers Municipal Infrastructure Revenue Bond Active ETF
RVNU
$132M
| $527K | ﹤0.01% |
21,947
+1,000
| +5% | +$24K |
2024 Q4
2 quarters
|
|
3978
Bread Financial
BFH
$3.72B
| $526K | ﹤0.01% |
+9,206
| New | +$464K |
2025 Q2
0 quarters
|
|
3979
AllianzIM U.S. Equity 6 Month Buffer10 Feb/Aug ETF
SIXF
$52M
| $526K | ﹤0.01% |
17,749
+1,391
| +9% | +$39.3K |
2024 Q4
2 quarters
|
|
3980
Innovator International Developed Power Buffer ETF February
IFEB
$56.9M
| $525K | ﹤0.01% |
18,392
-5,510
| -23% | -$152K |
2025 Q1
1 quarter
|
|
3981
State Street SPDR S&P Pharmaceuticals ETF
XPH
$526M
| $525K | ﹤0.01% |
12,928
-9,420
| -42% | -$379K |
2024 Q4
2 quarters
|
|
3982
Hingham Institution for Saving
HIFS
$624M
| $524K | ﹤0.01% |
+2,110
| New | +$510K |
2025 Q2
0 quarters
|
|
3983
National Beverage
FIZZ
$2.78B
| $523K | ﹤0.01% |
12,091
-1,768
| -13% | -$77.8K |
2024 Q4
2 quarters
|
|
3984
iShares MSCI Poland ETF
EPOL
$804M
| $522K | ﹤0.01% |
+16,194
| New | +$479K |
2025 Q2
0 quarters
|
|
3985
Fidelity MSCI Materials Index ETF
FMAT
$567M
| $522K | ﹤0.01% |
10,469
-1,295
| -11% | -$62.1K |
2024 Q4
2 quarters
|
|
|
ACVU
3986
Hartford Alpha Capture Value ETF
ACVU
$176M
| $521K | ﹤0.01% |
+20,314
| New | +$500K |
2025 Q2
0 quarters
|
|
3987
First Trust Global Wind Energy ETF
FAN
$197M
| $518K | ﹤0.01% |
28,583
-6,084
| -18% | -$100K |
2024 Q4
2 quarters
|
|
3988
Bausch Health
BHC
$2.14B
| $518K | ﹤0.01% |
77,838
+53,186
| +216% | +$273K |
2024 Q4
2 quarters
|
|
|
GGZ
3989
Gabelli Global Small and Mid-Cap Value Trust
GGZ
$118M
| $518K | ﹤0.01% |
38,887
+4,940
| +15% | +$61.1K |
2024 Q4
2 quarters
|
|
3990
Golar LNG
GLNG
$4.93B
| $517K | ﹤0.01% |
12,553
+5,897
| +89% | +$233K |
2024 Q4
2 quarters
|
|
3991
iShares BB Rated Corporate Bond ETF
HYBB
$300M
| $516K | ﹤0.01% |
+10,977
| New | +$505K |
2025 Q2
0 quarters
|
|
3992
iShares Morningstar Multi-Asset Income ETF
IYLD
$124M
| $516K | ﹤0.01% |
24,849
-15,051
| -38% | -$304K |
2024 Q4
2 quarters
|
|
|
CIVI
3993
DELISTED
Civitas Resources
CIVI
| $515K | ﹤0.01% |
18,724
+3,706
| +25% | +$107K |
2024 Q4
2 quarters
|
|
3994
NewtekOne
NEWT
$325M
| $515K | ﹤0.01% |
45,620
+7,674
| +20% | +$82K |
2024 Q4
2 quarters
|
|
|
PPI
3995
AXS Astoria Inflation Sensitive ETF
PPI
$156M
| $513K | ﹤0.01% |
31,372
-170
| -0.5% | -$2.55K |
2024 Q4
2 quarters
|
|
|
GLQ
3996
Clough Global Equity Fund
GLQ
$141M
| $510K | ﹤0.01% |
71,533
+2,832
| +4% | +$18.4K |
2024 Q4
2 quarters
|
|
|
ESGR
3997
DELISTED
Enstar Group
ESGR
| $510K | ﹤0.01% |
1,515
-2,209
| -59% | -$739K |
2024 Q4
2 quarters
|
|
|
IBTQ
3998
iShares iBonds Dec 2035 Term Treasury ETF
IBTQ
$253M
| $509K | ﹤0.01% |
+20,128
| New | +$503K |
2025 Q2
0 quarters
|
|
3999
Invesco Biotechnology & Genome ETF
PBE
$415M
| $509K | ﹤0.01% |
7,937
-1,159
| -13% | -$71.8K |
2024 Q4
2 quarters
|
|
4000
NYLIM Candriam U.S. Large Cap Equity ETF
IQSU
$351M
| $505K | ﹤0.01% |
10,182
+1,048
| +11% | +$48.5K |
2024 Q4
2 quarters
|
|
Similar funds
Raymond James Financial's Q2 2025 Portfolio in Review
As of Q2 2025, Raymond James Financial held 7,081 positions worth $290B, up 9.4% from $266B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Raymond James Financial's Q2 2025 filing shows 2,183 new, 2,404 increased, 2,172 reduced and 80 closed positions. Its largest new stake was ServiceTitan Inc: 369,922 shares worth $39.6M. The largest sale was Merck, an estimated $636M.
By sector, the portfolio is most concentrated in Miscellaneous at 40% of assets, down from 40% a quarter earlier, followed by Technology and Financials.
- Raymond James Financial's largest Q2 2025 buy was ServiceTitan Inc: 369,922 shares worth $39.6M.
- Raymond James Financial added most to Vanguard S&P 500 ETF in Q2 2025, an estimated $962M increase.
- Raymond James Financial's biggest Q2 2025 reduction was Merck, cutting an estimated $636M.
- Raymond James Financial fully exited Discover Financial Services in Q2 2025, selling an estimated $36.8M.
- Raymond James Financial's ten largest holdings make up 22% of its $290B portfolio in Q2 2025.
- Raymond James Financial opened 2,183 new positions and closed 80 in Q2 2025.
- Raymond James Financial's portfolio value rose 9.4% quarter-over-quarter to $290B.
Based on Raymond James Financial's 13F filing for Q2 2025, filed 14 Aug 2025.